Allergan posts loss as it writes down Teva holdings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Teva Pharma (TEVA) Sees Active Put Buying Ahead of Earnings Announcement Tomorrow BMC -Susquehanna
May 10, 2017 2:29 PM EDTSusquehanna options strategist Alison Edwards notes protective or bearish activity in Teva Pharma (NYSE: TEVA), as investors purchased ~9000 June 30 Puts and ~2000 May12 30 Puts today, ahead of the company's earnings report tomorrow before the market open.
